BIOCYTICS AND EREMID GENOMIC SERVICES COLLABORATE ON RESEARCH STUDY FOR NOVEL SINGLE-CELL TRANSCRIPTOMICS IMMUNE-BASED CANCER CELL THERAPY

Summary

BioCytics has engaged Eremid Genomic Services to perform single-cell transcriptomic sequencing on an autologous immune cell fraction for BioCytics' immune-based cancer cell therapy program. This is a research collaboration to support characterization of a leading therapeutic candidate.